|
|
|
Corporate Profile: Enzon
| Summary: |
Enzon, Inc.
is a biopharmaceutical company developing and commercializing
enhanced therapeutics for life-threatening diseases
through the application of its proprietary technologies,
PEG-Modification or PEG and Single-Chain Antibodies
(SCA®). |
| Address (HQ): |
20 Kingsbridge Road
Piscataway, NJ 08854 |
| Phone #'s (HQ): |
Main |
(732) 980-4500 |
| Human Resources |
not known |
| Investor Relations |
not known |
| Fax #'s (HQ): |
Main |
not known |
| Human Resources |
not known |
| Investor Relations |
not known |
| Financial
information: |
| ENZN |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
